“Blood Tests replace Surgical Biopsies to create a new multibillion dollar market opportunity .....”
The Screening Test opportunity is explored.
New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The biggest numbers we’ve seen in the Clinical Diagnostics space. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.
This independent research gives you the facts to speak with authority.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research Seminar - Burke Institute
Finance for Senior Executives - Harvard Business School
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook